Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Neuroinflammation|November 10, 2010
Characterization of human platelet binding of recombinant T cell receptor ligandAsako Itakura, Joseph E Aslan, Sushmita Sinha, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cellsAndrew P Fontenot, Timothy S Keizer, Mark McCleskey, et al.Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.Metabolic Brain Disease|January 14, 2025
The CD74 inhibitor DRhQ improves short-term memory and mitochondrial function in 5xFAD mouse model of Aβ accumulationNoah Gladen-Kolarsky, Cody J Neff, Wyatt Hack, et al.Plos Biology|November 22, 2024
CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cellsBianca Pellegrino, Keren David, Stav Rabani, et al.Translational Stroke Research|December 5, 2019
A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental StrokeJea-Young Lee, Vanessa Castelli, Brooke Bonsack, et al.Journal of Chemical Technology and Biotechnology (Oxford, Oxfordshire : 1986)|September 14, 2012
Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activityJianya Y Huan, Roberto Meza-Romero, Jeffery L Mooney, et al.Bioengineering (Basel, Switzerland)|January 8, 2025
Weighted Coherence Analysis as a Window into the Neurophysiological Effects of Traumatic Brain InjuryIgnacio Méndez-Balbuena, Brenda Lesly Betancourt-Navarrete, Ana Cristina Hermosillo-Abundis, et al.Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
MIF and D-DT are potential disease severity modifiers in male MS subjectsGil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.Pageof 4